Details of the Drug Reposition

General Information of This Drug (ID: DMVUXLC)

Drug Name
ST-101   DMVUXLC
Synonyms
ST 101 [French]; 7-Chloro-1,3-dihydro-5-phenyl-1-trimethylgermyl-2H-1,4-benzodiazepin-2-one; Trimethyl germyl-1, chloro-7, dihydro-1-3, phenyl-5 2H benzodiazepine-1-4 one-2 [French]; 2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-7-chloro-5-phenyl-1-trimethylgermyl-; AC1O4GHW; ST 101; LS-34275; Trimethyl germyl-1, chloro-7, dihydro-1-3, phenyl-5 2H benzodiazepine-1-4 one-2
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Anxiety disorder DISBI2BT 6B00-6B0Z Phase 2 [1]
Alzheimer disease DISF8S70 8A20 Phase 2 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT00842673) Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Disease. U.S. National Institutes of Health.